Perioperative β blockade: Guidelines do not reflect the problems with the evidence from the DECREASE trials

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  Cole, Graham D ^a   Francis, Darrel P ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL RESEARCH; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; PATIENT SAFETY; PEER REVIEW; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL SECRECY; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCIENTIFIC MISCONDUCT; STRESS ECHOCARDIOGRAPHY; SURGICAL MORTALITY; SURGICAL PATIENT; SYSTEMATIC ERROR; VALIDITY; CLINICAL TRIAL (TOPIC); MYOCARDIAL ISCHEMIA; PROCEDURES; STANDARDS;

ADRENERGIC BETA-ANTAGONISTS; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; MYOCARDIAL ISCHEMIA; PERIOPERATIVE CARE; PRACTICE GUIDELINES AS TOPIC; SCIENTIFIC MISCONDUCT;

EID: 84907320877     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g5210     Document Type: Article

References (36)

1. Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery, European Society of Cardiology (ESC), Poldermans D, Bax JJ, Boersma E, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009;30:2769-812.
2. Erasmus Medical College. Erasmus MC dismisses professor. Press release, November 2011. www.erasmusmc.nl/corp-home/corp-news-center/2011/2011-11/ontslag. hoogleraar/?lang=en.
3. Bouri S, Shun-Shin M, Cole GD, Mayet J, Francis DP. Meta-analysis of secure randomized controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery. Heart 2014;100:456-64.
4. Joint Task Force on Non-Cardiac Surgery Cardiovascular Assessment and Management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J 2014 Aug. 1. [Epub ahead of print.]
5. McGory ML, Maggard MA, Ko CY. A meta-analysis of peri-operative beta blockade: what is the actual risk reduction? Surgery 2005;138:171-9.
6. Angeli F, Verdecchia P, Karthikeyan G, Mazzotta G, Gentile G, Reboldi G. Beta-blockers reduce mortality in patients undergoing high-risk non-cardiac surgery. Am J Cardiovasc Drugs 2010;10:247-59.
7. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LLM, Blankensteijn T, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999;341:1789-94.
8. Dunkelgrun M, Boersma E, Schouten O, Koopman-van Gemert AW, van Poorten F, Bax JJ, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg 2009;249:921-6.
9. Poldermans D, Boersma E, Bax JJ, Thomson IR, Paelinck B, van de Ven LLM, et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001;22:1353-8.
10. Erasmus Medical Centre. Investigation into possible violation of scientific integrity. Report summary. 2011. www.erasmusmc.nl/5663/135857/ 3664573/3397899/report-summary-investigation-integrity.
11. Erasmus Medical Centre Follow-up Investigation Committee. Report on the 2012 follow-up investigation of possible breaches of academic integrity 2012. www.erasmusmc.nl/5663/135857/3675250/3706798/Integrity-report-2012-10.pdf?lang= en&lang=en.
12. European Society of Cardiology. Beta blockers and perioperative care: European Heart Journal editorial addresses controversy. Press release, 7 Feb. 2014. www.escardio.org/about/press/press-releases/pr-14/Pages/Beta-Blockers- Perioperative-Care-EHJ-Editorialaddresses-controversy.aspx.
13. Lüscher TF, Gersh B, Landmesser U, Ruschitzka F. Is the panic about beta-blockers in perioperative care justified? Eur Heart J 2014 Feb. 6. [Epub ahead of print.]
14. Erasmus Medical College. Further research academic integrity: other Poldermans' publications vetted [in Dutch]. Press release, 25 July 2014. www.erasmusmc.nl/perskamer/archief/2014/4761230.
15. Biccard BM, Sear JW, Foex P. Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes. Br J Anaesth 2008;100:23-8.
16. European Society of Cardiologists. Recommendations for guideline production. General conditions of a non-disclosure agreement. www.escardio.org/guidelines-surveys/escguidelines/OtherDocuments/ Non-Disclosure-Agreement-2014.pdf.
17. European Society of Cardiology. Press release, 23 November 2011. www.escardio.org/about/press/press-releases/pr-11/Pages/Dismissal-Don- Poldermans.aspx.
18. European Society of Cardiology. Recommendations for guideline production. www.escardio.org/guidelines-surveys/esc-guidelines/Documents/ ESC%20Guidelines%20for% 20Guidelines%20Update%202010.pdf.
19. European Society of Cardiology. Regarding the situation of Professor Don Poldermans, previously chairman of the task force for the "Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. www.escardio.org/about/press/press-releases/pr-13/Pages/ esc-statement-poldermans-guidelines-noncardiac-surgery.aspx.
20. European Society of Cardiology. ESC statement concerning pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery, 1 August 2013. www.escardio.org/about/press/press-releases/pr-13/Pages/ Statement-Perioperative-Guidelines.aspx.
21. Joint statement issued by the American College of Cardiology, American Heart Association and the European Society of Cardiology, 5 August 2013. www.escardio.org/about/press/press-releases/pr-13/Pages/joint-statement- perioperative-guidelines.aspx.
22. Schouten O, Poldermans D, Visser L, Kertai MD, Klein J, van Urk H, et al. Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: rationale and design of the DECREASE-IV study. Am Heart J 2004;148:1047-52.
23. London MJ, Hur K, Schwartz GG, Henderson WG. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 2013;309:1704-13.
24. European Society of Cardiology. Cardio newswire, 1 May 2014. http://web.archive.org/web/20140822220503/http://www.oxfordjournals.org/ our-journals/eurheartj/cardio-newswire-archive.html.
25. POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839-47.
26. Lüscher TF. The codex of science: honesty, precision, and truth- and its violations. Eur Heart J 2013;34:1018-23.
27. Sandberg A, Abrahamsson B, Regårdh CG, Wieselgren I, Bergstrand R. Pharmacokinetic and biopharmaceutic aspects of once daily treatment with metoprolol CR/ZOK: a review article. J Clin Pharmacol 1990;30:S2-16.
28. Sandberg A, Abrahamsson B, Svenheden A, Olofsson B, Bergstrand R. Steady-state bioavailability and day-to-day variability of a multiple-unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing. Pharm Res 1993;10:28-34.
29. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, et al. Prophylactic atenolol reduces post-operative myocardial ischemia. McSPI Research Group. Anesthesiology 1998;88:7-17
30. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Peri-operative Ischemia Research Group. New Engl J Med 1996;335:1713-20.
31. Bolsin S, Colson M, Marsiglio A. Perioperative β blockade. BMJ 2013 Sep. 19;347:f5640.
32. Swedberg K, Wedel H. 2-year survival with atenolol administration. Evid Based Cardiovasc Med 1998;2:33.
33. Neuman MD, Bosk CL, Fleisher LA. Learning from mistakes in clinical practice guidelines: the case of perioperative β-blockade. BMJ Qual Saf 2014. Aug. 18. [Epub ahead of print.]
34. Pinto FJ. Curriculum vitae. www.escardio.org/about/board-elections/ Documents/2012/CV-PINTO-Fausto.pdf.
35. Pogue JM, Devereaux PJ, Thorlund K, Yusuf S. Central statistical monitoring: detecting fraud in clinical trials. Clin Trials 2013;10:225-35.
36. Cole GD, Francis DP. The challenge of delivering reliable science and guidelines: opportunities for all to participate. Eur Heart J 2014 (accepted for publication 16 June 2014).